Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies ; volume:8 ; number:1 ; day:22 ; month:6 ; year:2020 ; pages:1-17 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (22.6.2020), 1-17, 12.2020

Creator: Xia, Yuxing
Prokop, Stefan
Gorion, Kimberly-Marie M.
Kim, Justin D.
Sorrentino, Zachary A.
Bell, Brach M.
Manaois, Alyssa N.
Chakrabarty, Paramita
Davies, Peter
Giasson, Benoit I.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-020-00967-w

URN: urn:nbn:de:101:1-2020081822061971221619

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Xia, Yuxing
Prokop, Stefan
Gorion, Kimberly-Marie M.
Kim, Justin D.
Sorrentino, Zachary A.
Bell, Brach M.
Manaois, Alyssa N.
Chakrabarty, Paramita
Davies, Peter
Giasson, Benoit I.
SpringerLink (Online service)

Other Objects (12)

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Related objects

Reset password